California State Teachers Retirement System (CalSTRS)’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Sell
15,442
-12,968
-46% -$209K ﹤0.01% 2161
2025
Q4
$459K Buy
28,410
+4,024
+17% +$53.3K ﹤0.01% 2124
2025
Q3
$297K Buy
24,386
+21,875
+871% +$302K ﹤0.01% 2215
2025
Q2
$28.4K Hold
2,511
﹤0.01% 2398
2025
Q1
$29K Hold
2,511
﹤0.01% 2426
2024
Q4
$21.3K Sell
2,511
-342
-12% -$3.54K ﹤0.01% 2581
2024
Q3
$33K Buy
2,853
+94
+3% +$1.18K ﹤0.01% 2466
2024
Q2
$32.5K Sell
2,759
-389
-12% -$4.54K ﹤0.01% 2467
2024
Q1
$37.3K Sell
3,148
-1,948
-38% -$26K ﹤0.01% 2544
2023
Q4
$62.4K Sell
5,096
-338
-6% -$3.08K ﹤0.01% 2542
2023
Q3
$52.3K Sell
5,434
-2,758
-34% -$28.2K ﹤0.01% 2697
2023
Q2
$73.7K Sell
8,192
-908
-10% -$8.37K ﹤0.01% 2763
2023
Q1
$71.5K Sell
9,100
-671
-7% -$5.01K ﹤0.01% 2765
2022
Q4
$66.1K Buy
9,771
+110
+1% +$589 ﹤0.01% 2864
2022
Q3
$140K Sell
9,661
-806
-8% -$11.3K ﹤0.01% 2709
2022
Q2
$103K Buy
10,467
+836
+9% +$9.22K ﹤0.01% 2871
2022
Q1
$142K Sell
9,631
-2,667
-22% -$38.3K ﹤0.01% 2766
2021
Q4
$163K Buy
12,298
+1,565
+15% +$24.9K ﹤0.01% 2857
2021
Q3
$187K Sell
10,733
-16,682
-61% -$338K ﹤0.01% 2770
2021
Q2
$657K Sell
27,415
-1,324
-5% -$34.6K ﹤0.01% 2486
2021
Q1
$738K Buy
28,739
+6,659
+30% +$175K ﹤0.01% 2328
2020
Q4
$419K Buy
22,080
+1,674
+8% +$28.7K ﹤0.01% 2497
2020
Q3
$257K Buy
20,406
+860
+4% +$10.8K ﹤0.01% 2606
2020
Q2
$237K Hold
19,546
﹤0.01% 2636
2020
Q1
$150K Buy
19,546
+225
+1% +$3.04K ﹤0.01% 2670
2019
Q4
$344K Buy
19,321
+1,350
+8% +$17.6K ﹤0.01% 2543
2019
Q3
$208K Hold
17,971
﹤0.01% 2775
2019
Q2
$398K Buy
+17,971
New +$421K ﹤0.01% 2490
2016
Q2
Sell
-2,360
Closed -$21K 3022
2016
Q1
$21K Buy
2,360
+738
+45% +$13.2K ﹤0.01% 2967
2015
Q4
$82K Buy
1,622
+29
+2% +$1.52K ﹤0.01% 2974
2015
Q3
$80K Sell
1,593
-7
-0.4% -$597 ﹤0.01% 2994
2015
Q2
$160K Buy
+1,600
New +$159K ﹤0.01% 2963

Other funds holding KALV

California State Teachers Retirement System (CalSTRS)'s KALV Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its KalVista Pharmaceuticals (KALV) stake by 46% in Q1 2026, selling an estimated $209K and leaving 15,442 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

California State Teachers Retirement System (CalSTRS) first reported a position in KALV in Q2 2015 and has held it in 32 quarters since. The position peaked at $738K in Q1 2021. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 15,442 shares of KalVista Pharmaceuticals worth $311K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 12,968 KalVista Pharmaceuticals shares in Q1 2026, an estimated $209K.
  • KalVista Pharmaceuticals made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2161 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in KalVista Pharmaceuticals in Q2 2015 and has held it in 32 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s KalVista Pharmaceuticals position peaked at $738K in Q1 2021.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.